MedTrace Logo

Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms

NCT06016543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2024-07-30

No results posted yet for this study

Summary

The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID-19 symptoms. The main questions it aims to answer are:

1. Is it feasible to conduct a large-scale study of the effect of OMT on patients with post-COVID-19 symptoms (based on how many patients agree to participate and how many complete the study)?
2. How much change in patients' post-COVID-19 symptom severity, quality of life, and ability to return to work can we expect to see following OMT?

Participants will receive OMT as directed by their physician and complete questionnaires after every other OMT session.

1. Participants will complete questionnaires about their post-COVID-19 symptoms, quality of life, ability to return to work, and adverse events they experienced 3 days after every other OMT session.
2. Participants will be sent links to the questionnaires for 4 months or when their symptoms resolve, whichever comes first.
3. Additionally, participants will complete a follow-up questionnaire 2 months after they stop receiving OMT for their post-COVID-19 symptoms or 6 months after enrollment in the study, whichever comes first.

Conditions

  • Post-Acute COVID-19 Syndrome

Interventions

PROCEDURE

osteopathic manipulative treatment (OMT)

Osteopathic manipulative treatment provided at the discretion of the treating physician and based on the patient's response to previous treatments.

Sponsors & Collaborators

  • American Osteopathic Association

    collaborator OTHER

  • A.T. Still University of Health Sciences

    lead OTHER

Principal Investigators

  • Brian F Degenhardt, DO · A.T. Still University of Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-18
Primary Completion
2024-07-10
Completion
2024-07-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06016543 on ClinicalTrials.gov